logo
Select company
Select metric
$ -11.99MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
24
Sector
58
Industry
75
History
15
$ 2.98Close
$ 1.05 - $ 7.71 52-Week Range
Ticker Information

Ticker

THAR

Company Name

THARIMMUNE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

THARIMMUNE INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

THAR - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 0$ -11.99M$ -11.99M
3/31/2025$ 0$ -12.47M$ -12.47M
12/31/2024$ 0$ -12.18M$ -12.18M
9/30/2024$ 0$ -10.84M$ -10.84M
6/30/2024$ 0$ -8.86M$ -8.86M
3/31/2024$ 0$ -8.87M$ -8.87M
12/31/2023$ 0$ -9.3M$ -9.3M
9/30/2023$ 0$ -8.6M$ -8.6M
6/30/2023$ 0$ -8.91M$ -8.91M
3/31/2023$ 0$ -8.21M$ -8.21M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • THARIMMUNE INC's latest trailing twelve months (TTM) EBITDA stands at $ -2.17M.
  • Over the past 5 years, THARIMMUNE INC's average EBITDA has been $ -8.08M.
  • The median EBITDA for THARIMMUNE INC during this period was $ -8.87M
  • THARIMMUNE INC reached its highest EBITDA over the past 5 years at $ -1.38M.
  • The lowest EBITDA recorded by THARIMMUNE INC in the same timeframe $ -12.47M

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA
EBITDA for THARIMMUNE INC is calculated as follows: EBIT [ $ -2.17M ] + DepAmor [ $ 0 ]
(=) EBITDA [ $ -2.17M ]

THAR - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -12.47M

Minimum

Mar 31, 2025

$ -1.38M

Maximum

Dec 31, 2021

$ -8.08M

Average

$ -8.87M

Median

EBITDA Benchmark Analysis

The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M